News Digest / Ticker: ROIV

Ticker: ROIV

08:04am, Monday, Aug 11, 2025

Roivant Q3 operating loss widens as R&D and G&A surge; $4.5B liquidity, buybacks continue

Roivant Sciences Ltd. (NASDAQ: ROIV) - Quick inside view (Q3 FY2025, unaudited) Short take: Roivant is spending aggressively to advance its pipeline - R&D and G&A rose sharply this quarter - while sitting on a large liquid balance sheet (~$4.5B). The income statement shows a large operating loss ...

03:31am, Tuesday, Feb 11, 2025

Roivant Sciences' Income Statement: Mixed Results Amid Revenue Decline and High R&D Spending